期刊文献+

曲安奈德辅助玻璃体后皮质可视化在玻璃体切割术中的应用

The application of the triamicinlone acetonide as an aid to visualization of the vitreous during pars plana vitrectomy
下载PDF
导出
摘要 目的探讨玻璃体切割术中应用曲安奈德(TA)辅助下使后皮质可视化造玻璃体后脱离的临床效果。方法对49例53眼行玻璃体切割术的患者,术中切除中央部玻璃体后,后极部注入0.2mlTA,在TA辅助下造玻璃体后脱离,观察玻璃体完全后脱离、后皮质残留及并发症发生的情况。结果53眼术中有8只眼发生玻璃体完全后脱离,发生率为15%,弥漫性玻璃体皮质残留29只眼,占55%;局限性玻璃体皮质残留16只眼,占30%;6只眼(11%)发生一过性高眼压,经治疗后好转,3只眼(6%)硅油填充眼出现晶状体混浊加重,无需进行手术。结论TA辅助下造玻璃体后脱离在玻璃体切割术中具有安全、手术效率高、并发症少等优点。 Objective To investigate the effects of TA as an aid visualization of the vitreous to make posterior vitreous detachment during pars plana vitrectomy. Methods Forty -nine patients (53 eyes) underwent PPV with TA, after removal anterior core vitreous,0. 2 ml(8 mg) TA was injected into the midvitreous cavity to visualize the posterior hyaloid. Completely posterior vitreous detachment, residual vitreous cortex, and complications were recoreded. Results all patients ,completely posterior vitreous detachment occurred in 8 eyes ( 15% ) ,widespread residual vitreous cortex in 29 eyes (55%) ,local residual vitreous cortex in 16 eyes (30%) ,6 eyes ( 11% ) elevation of the IOP between 25 and 45 mmHg,3 eyes (6%) had cataract progression,but had no significantly acuity effect. Conclusions The application of TA during pars plana vitrectomy is safety, helpful for improve surgery rate and less complications.
出处 《医学信息(内.外科版)》 2009年第4期333-334,共2页 Medical Information Operations Sciences Fascicule
关键词 曲安奈德 玻璃体后脱离 玻璃体切割 triamicinlone acetonide (TA) posterior vitreous detachment (PVD) vitrectomy
  • 相关文献

参考文献9

  • 1何建忠,许春丽,Ong SG.曲安奈德辅助玻璃体切割术的应用[J].中国实用眼科杂志,2005,23(11):1186-1188. 被引量:3
  • 2张明,马麟,张军军,刘谊.曲安奈德在玻璃体视网膜手术中的应用[J].中华眼底病杂志,2005,21(4):226-228. 被引量:12
  • 3Peyman GA,Cheema R,CONway MD,et al.Triamicinlone acetonide as an aid to visualization of the vitreous and the posterior hyaliod during pars plana vitrectomy[J].Retina,2000,20:554-555.
  • 4陈长征,邢怡桥.曲安奈德在玻璃体切割术中的辅助应用[J].国外医学(眼科学分册),2004,28(6):387-390. 被引量:17
  • 5Kinura H,Huroda S,Naata M.Tramcinolone acetonide assisted peeling of the internal limiting membrane[J].Am J opthalmol,2004,137:172-173.
  • 6张静琳,叶荣花,吕林,李永浩.曲安奈德璃体腔内注射在糖尿病视网膜病变手术中的运用[J].中华眼底病杂志,2005,21(4):244-244. 被引量:14
  • 7Jouas JB,Hayler JK,Sofker A,et al.Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy[J].Am J Ophthalmol,2001,131:468 -471.
  • 8Sakamoto T,Miyazaki M,Hisatomi T,et al.Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown[J].Graefes Arch Clin Exp Ophthalmol,2002,240:423-429.
  • 9Ozkiris A,Erkilic K.Compilications of intravitreal injection of triamicinlone acetonide[J].Can J Ophthalmolo,2005,40:63 -68.

二级参考文献49

  • 1Kumagai K. Introduction of a new method for the preparation of triamcinolone acctonide solution as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina, 2003, 23(6):881-882.
  • 2Jonas JB, Sofker A, Hayler J, et al. lntravitreal crystalline triamcinolone acetonide as an additional tool in pars plana vitrectomy for complicated proliferative vitreoretinopathy? Acta Ophthalmol Scand, 2003,81 (6) :663-665.
  • 3Sakamoto T, Miyazaki M, Hisatomi T, et al. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol, 2002, 240(6):423-429.
  • 4Hollborn M, Birkenmeier G, Saalbach A, et al. Expression of LRP1 in retinal pigment epithelial cells and its regulation by growth factors. Invest Ophthalmol Vis Sci, 2004, 45(6) :2033-2038.
  • 5Enaida H, Hata Y, Ueno A, et al. Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases. Retina, 2003,23(6) :764-770.
  • 6Furino C, Micelli Ferrari T, Boscia F, et al. Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy. Retina,2003, 23(6) :771-776.
  • 7Jonas JB. Intravitreal triamcinolone acetonide as treatment for extensive exudative retinal detachment. Br J Ophthalmol, 2004, 88(4) :587-588.
  • 8Enaida H, Sakamoto T, Ueno A, et al. Submacular deposition of triamcinolone acetonide after triamcinolone-assisted vitrectomy. Am J Ophthalmol, 2003, 135(2) :243-246.
  • 9Matsumoto H, Enaida H, Hisatomi T, et al. Retinal detachment in morning glory syndrome treated by triamcinolone acetonide-assisted pars plana vitrectomy. Retina, 2003, 23(4):569-572.
  • 10Fraser EA, Cheema RA, Roberts MA. Triamcinolone acetonideassisted peeling of retinal internal limiting membrane for macular surgery. Retina, 2003, 23(6):883-884.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部